{"symbol": "CTLT", "companyName": "Catalent Inc.", "exchange": "NEW YORK STOCK EXCHANGE, INC.", "industry": "Pharmaceutical Preparation Manufacturing ", "website": "www.catalent.com", "description": "Catalent, Inc., an S&P 500\u00ae Company, is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs over 14,000 people, including over 2,400 scientists and technicians, at more than 40 facilities across four continents, and in fiscal year 2020 generated over $3 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey.", "CEO": "", "securityName": "Catalent Inc.", "issueType": "cs", "sector": "Manufacturing", "primarySicCode": 2834, "employees": 13900, "tags": ["Health Technology", "Pharmaceuticals: Other", "Manufacturing", "Pharmaceutical Preparation Manufacturing "], "address": null, "address2": null, "state": null, "city": null, "zip": null, "country": null, "phone": null}